Back
TransMedics Group Quote, Financials, Valuation and Earnings
Sponsored
TMDX
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
41
TMDX
TransMedics Group
Last Price:
80.55
Seasonality Move:
29.84%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereTransMedics Group Price Quote
$80.55
+0.07 (+-8.84%)
(Updated: November 16, 2024 at 5:41 AM ET)
TransMedics Group Key Stats
Sell
41
TransMedics Group (TMDX)
is a Sell
Day range:
$80.06 - $88.93
52-week range:
$63.86 - $177.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.62
P/B ratio:
14.13%
Volume:
2.3M
Avg. volume:
1.8M
1-year change:
22.7%
Market cap:
$3B
Revenue:
$241.6M
EPS:
$0.94
How Much Does TransMedics Group Make?
-
How Much Are TransMedics Group's Sales Annually?
TMDX Revenues are $241.6M -
How Much Profit Does TransMedics Group's Make A Year?
TMDX net income is -$25M
Is TransMedics Group Growing As A Company?
-
What Is TransMedics Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.64% -
What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
TransMedics Group Stock Price Performance
-
Did TransMedics Group Stock Go Up Last Month?
TransMedics Group share price went down by -38.96% last month -
Did TMDX's Share Price Rise Over The Last Year?
TMDX share price rose by 22.7% over the past 1 year
What Is TransMedics Group 52-Week High & Low?
-
What Is TransMedics Group’s 52-Week High Share Price?
TransMedics Group has traded as high as $177.37 over the past 52 weeks -
What Is TransMedics Group’s 52-Week Low Share Price?
TransMedics Group has traded as low as $63.86 over the past 52 weeks
TransMedics Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy TransMedics Group?
-
How Much Debt Does TransMedics Group Have?
Total long term debt quarterly is $508.5M -
How Much Cash Does TransMedics Group Have?
Cash and short term investments quarterly total is $330.1M -
What Is TransMedics Group’s Book Value Per Share?
Book value per share is 6.25
Is TransMedics Group Cash Flow Positive?
-
What Is TMDX Cash Flow From Operations?
Cash flow from operations (TTM) is $37.4M -
What Is TransMedics Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is $22.6M -
What Is TransMedics Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$157.5M
TransMedics Group Return On Invested Capital
-
Is Management Doing A Good Job?
TMDX return on invested capital is 4.86% -
What Is TransMedics Group Return On Assets?
ROA measures how assets are converting to revenues and is 4.46% -
What Is TMDX Return On Equity?
ROE is a measure of profitability and is 19.83%
TransMedics Group Earnings Date & Stock Price
-
What Is TransMedics Group's Stock Price Today?
A single share of TMDX can be purchased today for 80.48 -
What Is TransMedics Group’s Stock Symbol?
TransMedics Group trades on the nasdaq under the ticker symbol: TMDX -
When Is TransMedics Group’s Next Earnings Date?
The next quarterly earnings date for TransMedics Group is scheduled on February 26, 2025 -
When Is TMDX's next ex-dividend date?
TransMedics Group's next ex-dividend date is May 26, 2020 -
How To Buy TransMedics Group Stock?
You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
TransMedics Group Competitors
-
Who Are TransMedics Group's Competitors?
Below is a list of companies who compete with TransMedics Group or are related in some way:
TransMedics Group Dividend Yield
-
What Is TMDX Dividend Yield?
TransMedics Group’s dividend yield currently is 0% -
What Is TransMedics Group’s Payout Ratio?
TransMedics Group’s payout ratio is 0% -
When Did TransMedics Group Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is TransMedics Group’s Dividend Per Share?
TransMedics Group pays a dividend of $0.00 per share
TransMedics Group Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -62.31% |
Revenue: | 63.72% | -5.42% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 136.67 |
Upside from Last Price: | 69.81% |